Research progress in OX40/OX40L in allergic diseases
- PMID: 39404736
- DOI: 10.1002/alr.23469
Research progress in OX40/OX40L in allergic diseases
Abstract
OX40/OX40L are costimulatory molecules in the tumor necrosis factor superfamily. Numerous studies have shown that OX40/OX40L are involved in immune regulation, especially in the proliferation and differentiation of T cells and the generation of memory T cells, which play important roles in allergic diseases. In recent years, the use of OX40/OX40L as therapeutic targets for treating T-cell-mediated diseases has attracted the interest of scholars. This paper reviews the role of OX40/OX40L in allergic diseases and the progress in clinical treatments targeting this signaling pathway.
Keywords: OX40; OX40L; allergic rhinitis; asthma; atopic dermatitis.
© 2024 ARS‐AAOA, LLC.
Similar articles
-
The role of OX40 ligand/OX40 axis signalling in atopic dermatitis.Br J Dermatol. 2024 Sep 18;191(4):488-496. doi: 10.1093/bjd/ljae230. Br J Dermatol. 2024. PMID: 38836560 Review.
-
Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes.Front Immunol. 2025 Jan 10;15:1473815. doi: 10.3389/fimmu.2024.1473815. eCollection 2024. Front Immunol. 2025. PMID: 39867912 Free PMC article.
-
OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.Adv Immunol. 2010;105:63-98. doi: 10.1016/S0065-2776(10)05003-0. Adv Immunol. 2010. PMID: 20510730 Review.
-
Control of immunity by the TNFR-related molecule OX40 (CD134).Annu Rev Immunol. 2010;28:57-78. doi: 10.1146/annurev-immunol-030409-101243. Annu Rev Immunol. 2010. PMID: 20307208 Free PMC article. Review.
-
OX40/OX40L axis: not a friend in autoimmunity.Oncotarget. 2015 Sep 8;6(26):21779-80. doi: 10.18632/oncotarget.4973. Oncotarget. 2015. PMID: 26314852 Free PMC article. No abstract available.
Cited by
-
The management of type 2 inflammatory respiratory diseases: a Chinese expert consensus [2024].J Thorac Dis. 2025 Apr 30;17(4):1807-1831. doi: 10.21037/jtd-2024-2092. Epub 2025 Mar 25. J Thorac Dis. 2025. PMID: 40400979 Free PMC article. Review.
References
REFERENCES
-
- Zheng T, Yu J, Oh MH, Zhu Z. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res. 2011;3(2):67‐73.
-
- de Monchy JG, Demoly P, Akdis CA, et al. Allergology in Europe, the blueprint. Allergy. 2013;68(10):1211‐1218.
-
- Savouré M, Bousquet J, Jaakkola JJK, et al. Worldwide prevalence of rhinitis in adults: a review of definitions and temporal evolution. Clin Transl Allergy. 2022;12(3):e12130.
-
- Wang XD, Zheng M, Lou HF, et al. An increased prevalence of self‐reported allergic rhinitis in major Chinese cities from 2005 to 2011. Allergy. 2016;71(8):1170‐1180.
-
- Chakaya J, Aït‐Khaled N. Global Asthma Report 2022: a wake‐up call to enhance care and treatment for asthma globally. Int J Tuberc Lung Dis. 2022;26(11):999‐1000.
Publication types
MeSH terms
Substances
Grants and funding
- 2022YFS0629/Sichuan Science and Technology Program
- 2023LZXNYDJ012/Science and Technology Strategic Cooperation Project of Luzhou Municipal People's Government-Southwest Medical University
- 202310632038/2023 National College Student Innovation and Entrepreneurship Training Project
- 22154/Doctoral Research Initiation Fund of the Affiliated Hospital of Southwest Medical University
LinkOut - more resources
Full Text Sources
Medical